12 results about "Esophageal sphincter" patented technology

1. A surgical kit for performing surgery for the treatment of reflux disease, the surgical kit comprising the following components: An implantable motion restriction device configured to impede movement of the lower esophageal sphincter relative to the thoracic diaphragm, the device having at least a portion positioned between the angle of His and the thoracic diaphragm; a lubricant including an antimicrobial agent for use in combination with the implantable motion restriction device; and at least one absorbable suture.

The gastroesophageal collar being submitted for patent intends to primarily prevent the ascension of the fundus above the diaphragmatic plane and also secondarily to improve the function of the Lower esophageal sphincter, thirdly to reduce occurrences of esophageal reflux and thereby hopefully reducing instances of esophageal cancer. It is estimated as high as %20 of the general population has a hiatal hernia experiencing symptoms of acid reflux and making them at higher risk for esophageal cancer. Currently the standard surgical repair of hiatus is fundoplication. The limitations of fundoplication are its high recurrence rate. It often requires a later second procedure to repair / tighten the fundoplication. By using supple bio-inert materials we intend to create a collar that can be left in place, mechanically preventing the ascension of the fundus and improving LES function. We hope to be the first Collar to prevent hiatal hernia and also improve LES function.

The application relates to a composition for treating reflux esophagitis and application thereof. The composition comprises the following components in parts by weight: 2-8 parts of scutellaria baicalensis, 3-7 parts of licorice, 5-10 parts of beeswax and 80-120 parts of vegetable oil. The composition for treating reflux esophagitis contains scutellaria baicalensis, licorice, beeswax and vegetable oil, and through mutual cooperation among the components, the drug prepared from the composition can significantly increase the plasma motilin level of a patient, further increase the pressure of the lower esophageal sphincter, promote gastric emptying and prevent acid reflux, promote the recovery of reflux esophagitis, the esophagus of the patient is obviously improved, and no adverse reaction is found; meanwhile, the content of lipid peroxide can be obviously reduced, the activities of superoxide dismutase and glutathione peroxidase are increased, the esophageal mucosa is protected and treated, the pathological changes of the esophagus are obviously improved, and the treatment effect is excellent.

Systems and methods for treating gastroesophageal reflux disease (GERD) includes minimally invasively implanting a stimulating device in a patient's esophagus in the region proximate the lower esophageal sphincter (LES). The patient is provided with a questionnaire related to his disease via an online service. The questionnaire is accessed on a mobile device, such as a cell phone, or on a computer with network access. The data from the sensors and the answers from the questionnaire are analyzed together by a health care provider using the online service. The data and answers are used to program the stimulating device, via the mobile device or computer, to optimize treatment.

A surgical method of treating reflux disease comprising the steps of dissecting an outside of a fundus of a stomach at least partially down on a posterior side of the outside of the fundus, dissecting an esophagus such that the esophagus is disconnected from surrounding tissue at least 3 cm in a cranial direction from an angle of His, connecting the fundus to the esophagus, and placing an implantable movement restriction device between the angle of His and a diaphragm, such that a lower esophageal sphincter is prevented from sliding through an esophageal hiatus.

Systems and methods for treating a gastrointestinal condition of a patient includes minimally invasively implanting a modular or non-modular stimulation system in a patient's treatment site. The treatment site is in or on a gastric wall and electrical stimulation is provided to the gastric wall to improve a function or pressure a lower esophageal sphincter of the patient. Electrical stimulation is provided for a short period of time and treatment efficacy is evaluated through clinical results and patient reporting. If therapy is not effective, stimulation parameters may be changed.

An implantable medical device for treating reflux disease includes a movement restriction device configured to be anchored to the stomach wall to prevent movement of the lower esophageal sphincter relative to the thoracic diaphragm. The movement restriction device includes a first portion, a second portion, and a first distance element. The first and second portions are configured to be connected to each other to form at least a portion of a functional movement restriction device. The first and second portions are detachable from each other to allow the first and second portions to pass independently through the gastrointestinal tract, and the first distance element is configured to form a space between the first and second portions, the space being configured to allow fibrous tissue ingrowth between the first and second portions.

The present specification discloses devices and methodologies for the treatment of GERD. Individuals with GERD may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow, have improved energy storage requirements, enable improved LES function while concurrently delivering additional health benefits, and enable improved LES function post stimulation termination.

A surgical method of treating reflux disease comprising the steps of dissecting the fundus at least partially down on the posterior side thereof; in the approximate direction towards bursa Omentalis, as well as away from the spleen. The method further comprising the steps of dissecting the esophagus such that the esophagus is disconnected from the surrounding tissue at least 3 cm in a cranial direction from the angle of his and connecting the fundus to the esophagus by placing at least two posterior single sutures in a posterior suture line, or a posterior continuous suture line, connecting the fundus to the esophagus, on the sinister-posterior side of the esophagus, and placing at least two anterior sutures, in an anterior suture line, or an anterior continuous suture line, connecting the fundus to the esophagus, on the sinister-anterior side of the esophagus. The method further comprises placing an implantable movement restriction device between the angle of His and the diaphragm, such that the lower esophageal sphincter is prevented from sliding through the esophageal hiatus.

Systems and methods for treating a gastrointestinal condition of a patient includes minimally invasively implanting a modular or non-modular stimulation system in a patient's treatment site. The treatment site is in or on a gastric wall and electrical stimulation is provided to the gastric wall to improve a function or pressure a lower esophageal sphincter of the patient. Electrical stimulation is provided for a short period of time and treatment efficacy is evaluated through clinical results and patient reporting. If therapy is not effective, stimulation parameters may be changed.

The invention discloses an esophageal sphincter nerve stimulator which comprises a nerve stimulator body and two electrodes, the nerve stimulator body is connected with the two electrodes through a wire, the two electrodes are arranged at the front end of the probing end of the wire, and the nerve stimulator body provides stimulation treatment for esophageal sphincter muscles through the wire; mild electric signals are automatically sent to weak or dysfunctional lower esophageal sphincter muscles of a patient all day long, and long-term reflux is provided to control the nerve stimulator to automatically stimulate the lower esophageal sphincter muscles, so that the lower esophageal sphincter muscles work normally without causing any feeling to the patient.

The utility model belongs to the technical field of medical instruments, and particularly relates to a child stomach feeding bite device which comprises a chest plate and a fixing assembly arranged above the chest plate. The fixing assembly comprises a neck sleeve, a threaded rod, a face support, a spring and a biting device body, the neck sleeve is fixedly connected to the outer side of one end of the chest plate, and the threaded rod is fixedly connected to the outer side of the end of the neck sleeve; the throat part is supported by the neck sleeve and the face support, so that the throat part can be kept in a more upright and stable state, gastroesophageal reflux caused by gravity or other external factors is reduced, and meanwhile, the lower esophageal sphincter is an annular muscle and is responsible for maintaining normal pressure difference between the esophagus and the stomach and preventing reflux of contents in the stomach; by supporting the throat part, the sphincter under the esophagus can be indirectly helped to better exert the function of the sphincter under the esophagus, and the closing effect of the sphincter under the esophagus is enhanced, so that the occurrence of reflux events is reduced.